fk 156 has been researched along with ebelactone a in 1 studies
| Studies (fk 156) | Trials (fk 156) | Recent Studies (post-2010) (fk 156) | Studies (ebelactone a) | Trials (ebelactone a) | Recent Studies (post-2010) (ebelactone a) |
|---|---|---|---|---|---|
| 28 | 0 | 4 | 16 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Umezawa, H | 1 |
1 review(s) available for fk 156 and ebelactone a
| Article | Year |
|---|---|
Low-molecular-weight immunomodifiers produced by micro-organisms.
Topics: Alkaline Phosphatase; Aminopeptidases; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibody Formation; Diaminopimelic Acid; Glycine; Guanidines; Hypersensitivity, Delayed; Immune Tolerance; Immunity; Immunity, Cellular; Lactones; Leucine; Leukemia L1210; Mice; Molecular Weight; Oligopeptides; Peptides; Polycyclic Sesquiterpenes; Sesquiterpenes; T-Lymphocytes, Regulatory | 1985 |